Cell-based 3D bionic screening by mimicking the drug–receptor interaction environment in vivo
Author:
Affiliation:
1. Health Science Center
2. School of Pharmacy
3. Xi’an Jiaotong University
4. Xi’an
5. China
6. Department of Pharmacy
7. Shenzhen Children's Hospital
8. Shenzhen
Abstract
A cell-based screening method for drug lead target capture using a microcarrier covered with highly expressed receptor cells as a 3D biomimetic framework.
Funder
National Natural Science Foundation of China
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science,Biomedical Engineering,General Chemistry,General Medicine
Link
http://pubs.rsc.org/en/content/articlepdf/2021/TB/D0TB02661A
Reference34 articles.
1. The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type
2. Engineering extracellular matrix to improve drug delivery for cancer therapy
3. Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents
4. An analysis of FDA-approved drugs: natural products and their derivatives
5. Natural Products as Sources of New Drugs from 1981 to 2014
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immobilized cells on microcarriers for efficient and biomimetic screening of active compounds acting on FGFR4 from Fructus evodiae;Journal of Pharmaceutical and Biomedical Analysis;2024-09
2. A comprehensive review on 3D tissue models: Biofabrication technologies and preclinical applications;Biomaterials;2024-01
3. Supramolecular Responsive Chitosan Microcarriers for Cell Detachment Triggered by Adamantane;Polymers;2023-10-08
4. Unraveling the mystery of efficacy in Chinese medicine formula: New approaches and technologies for research on pharmacodynamic substances;Arabian Journal of Chemistry;2022-11
5. Dynamic behaviors of capsules on rough surfaces induced by shear flow under gravity;Physics of Fluids;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3